- This randomized controlled trial studied the effect of erythropoietin treatment in 941 extremely preterm infants between 24 and 27 weeks gestation. Infants received either erythropoietin or placebo intravenously for 6 doses then subcutaneously until 32 weeks postmenstrual age.
- The primary outcome of death or severe neurodevelopmental impairment at 2 years was not significantly different between the erythropoietin and placebo groups. No meaningful differences in serious adverse events were found.
- Unlike previous studies, this larger trial found that high-dose erythropoietin treatment did not reduce the risk of death or improve neurodevelopmental outcomes in extremely preterm infants compared to placebo.
This study aimed to compare the ability of serial cranial ultrasounds (CUS) and early MRI scans in detecting preterm brain injuries. The study found that CUS allowed for more scans due to better feasibility in the NICU, and was better at detecting grade I-II intraventricular hemorrhages and perforator strokes. MRI was superior for identifying smaller cerebellar hemorrhages and provided more quantitative data. Overall, the combination of serial CUS and MRI provided the highest sensitivity for detecting common preterm brain injuries, though MRI could not be performed in the sickest infants.
This study evaluated the use of sirolimus, an mTOR inhibitor, in 4 patients with diffuse hyperinsulinemic hypoglycemia that was unresponsive to standard treatments with diazoxide and octreotide. Patients received sirolimus with dose adjustments to achieve target serum levels. Glycemic control improved in all patients after starting sirolimus. The study suggests mTOR inhibitors may provide an alternative treatment option for severe hyperinsulinemic hypoglycemia unresponsive to other therapies, but larger and longer-term studies are still needed to fully evaluate efficacy and safety.
- Ocrelizumab (OCR) significantly reduced disability progression and disease activity in patients with primary progressive multiple sclerosis (PPMS) compared to placebo in the ORATORIO clinical trial.
- Evaluation of efficacy in subgroups of patients with and without T1 gadolinium-enhancing (Gd+) lesions at baseline was a key objective. OCR reduced disability progression and disease activity in both subgroups.
- Specifically, OCR reduced the risk of 12-week and 24-week confirmed disability progression by 24-25% in the overall population and in both subgroups. It also reduced the worsening of walking ability and brain lesion volume over 120 weeks compared to placebo.
1) A phase 3 clinical trial evaluated the efficacy of ocrelizumab in reducing disability progression in patients with primary progressive multiple sclerosis (PPMS) with and without T1 gadolinium-enhancing lesions at baseline.
2) Results showed that ocrelizumab reduced the risk of 12-week and 24-week confirmed disability progression by 24% and 25% respectively compared to placebo in the overall study population.
3) When analyzing subgroups based on presence of T1 lesions at baseline, ocrelizumab reduced risk of disability progression in both subgroups, though the results did not reach statistical significance in the subgroup with lesions at baseline.
This study analyzed 114 cases of neonatal Candida bloodstream infection from a tertiary care hospital in central India over 5 years. Non-albicans Candida (NAC) infections like C. tropicalis and C. parapsilosis were associated with higher mortality and longer hospital stays. Resistance to fluconazole and amphotericin B was also higher in NAC infections. Prolonged use of central lines, nil oral intake, mechanical ventilation and longer hospital stays were identified as risk factors. The study highlights the need for timely identification of Candida species and antifungal susceptibility testing to help improve outcomes.
This randomized controlled trial compared the effectiveness and safety of minimal stimulation IVF (mini-IVF) to conventional IVF. 564 women were randomly assigned to either mini-IVF using oral clomiphene and gonadotropins followed by a freeze-all policy, or conventional IVF using high dose gonadotropins and fresh double embryo transfer. The primary outcome was cumulative live birth rate within 6 months, and secondary outcomes included pregnancy rates, ovarian hyperstimulation syndrome, and multiple pregnancy rates. Results showed mini-IVF resulted in comparable live birth rates but significantly lower risks of ovarian hyperstimulation syndrome and multiple pregnancies compared to conventional IVF.
- This randomized controlled trial studied the effect of erythropoietin treatment in 941 extremely preterm infants between 24 and 27 weeks gestation. Infants received either erythropoietin or placebo intravenously for 6 doses then subcutaneously until 32 weeks postmenstrual age.
- The primary outcome of death or severe neurodevelopmental impairment at 2 years was not significantly different between the erythropoietin and placebo groups. No meaningful differences in serious adverse events were found.
- Unlike previous studies, this larger trial found that high-dose erythropoietin treatment did not reduce the risk of death or improve neurodevelopmental outcomes in extremely preterm infants compared to placebo.
This study aimed to compare the ability of serial cranial ultrasounds (CUS) and early MRI scans in detecting preterm brain injuries. The study found that CUS allowed for more scans due to better feasibility in the NICU, and was better at detecting grade I-II intraventricular hemorrhages and perforator strokes. MRI was superior for identifying smaller cerebellar hemorrhages and provided more quantitative data. Overall, the combination of serial CUS and MRI provided the highest sensitivity for detecting common preterm brain injuries, though MRI could not be performed in the sickest infants.
This study evaluated the use of sirolimus, an mTOR inhibitor, in 4 patients with diffuse hyperinsulinemic hypoglycemia that was unresponsive to standard treatments with diazoxide and octreotide. Patients received sirolimus with dose adjustments to achieve target serum levels. Glycemic control improved in all patients after starting sirolimus. The study suggests mTOR inhibitors may provide an alternative treatment option for severe hyperinsulinemic hypoglycemia unresponsive to other therapies, but larger and longer-term studies are still needed to fully evaluate efficacy and safety.
- Ocrelizumab (OCR) significantly reduced disability progression and disease activity in patients with primary progressive multiple sclerosis (PPMS) compared to placebo in the ORATORIO clinical trial.
- Evaluation of efficacy in subgroups of patients with and without T1 gadolinium-enhancing (Gd+) lesions at baseline was a key objective. OCR reduced disability progression and disease activity in both subgroups.
- Specifically, OCR reduced the risk of 12-week and 24-week confirmed disability progression by 24-25% in the overall population and in both subgroups. It also reduced the worsening of walking ability and brain lesion volume over 120 weeks compared to placebo.
1) A phase 3 clinical trial evaluated the efficacy of ocrelizumab in reducing disability progression in patients with primary progressive multiple sclerosis (PPMS) with and without T1 gadolinium-enhancing lesions at baseline.
2) Results showed that ocrelizumab reduced the risk of 12-week and 24-week confirmed disability progression by 24% and 25% respectively compared to placebo in the overall study population.
3) When analyzing subgroups based on presence of T1 lesions at baseline, ocrelizumab reduced risk of disability progression in both subgroups, though the results did not reach statistical significance in the subgroup with lesions at baseline.
This study analyzed 114 cases of neonatal Candida bloodstream infection from a tertiary care hospital in central India over 5 years. Non-albicans Candida (NAC) infections like C. tropicalis and C. parapsilosis were associated with higher mortality and longer hospital stays. Resistance to fluconazole and amphotericin B was also higher in NAC infections. Prolonged use of central lines, nil oral intake, mechanical ventilation and longer hospital stays were identified as risk factors. The study highlights the need for timely identification of Candida species and antifungal susceptibility testing to help improve outcomes.
This randomized controlled trial compared the effectiveness and safety of minimal stimulation IVF (mini-IVF) to conventional IVF. 564 women were randomly assigned to either mini-IVF using oral clomiphene and gonadotropins followed by a freeze-all policy, or conventional IVF using high dose gonadotropins and fresh double embryo transfer. The primary outcome was cumulative live birth rate within 6 months, and secondary outcomes included pregnancy rates, ovarian hyperstimulation syndrome, and multiple pregnancy rates. Results showed mini-IVF resulted in comparable live birth rates but significantly lower risks of ovarian hyperstimulation syndrome and multiple pregnancies compared to conventional IVF.
The document summarizes a study that evaluated the effects of probiotic treatment on depression-related behaviors in rats fed either a control or high-fat diet. Key findings include:
1. Probiotic treatment significantly lowered depressive-like behavior in rats and improved performance in memory tests, regardless of diet.
2. Probiotics modulated cytokine production and expression of genes related to the hypothalamic-pituitary-adrenal axis and neuroplasticity.
3. Metabolomic analysis found probiotics significantly affected 13 plasma metabolites involved in immune function, glucose regulation, and neurotransmission.
Comparative evaluation of 2g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections. Indian Journal Of Pharmacology. August 2015;Vol. 47; Issue 4
Actrims 2016 opera poster hauser_p024 (1)BartsMSBlog
The document summarizes results from two Phase III clinical trials called OPERA I and OPERA II that compared the efficacy and safety of ocrelizumab (OCR) to interferon beta-1a (IFN β-1a) in patients with relapsing multiple sclerosis (RMS). Key results include:
1) OCR significantly reduced annualized relapse rates (ARR) by 46-47% compared to IFN β-1a in both studies. OCR also reduced disability progression and brain lesion activity to a greater extent than IFN β-1a.
2) A higher proportion of patients on OCR achieved no evidence of disease activity compared to those on IFN β-1a.
February 9, 2018
In the past several years, the United States has struggled to respond to viral outbreaks, such as Ebola and Zika. There is now an awareness of the need to rapidly develop vaccines and treatments for epidemics that can quickly spread from country to country. But questions remain as how to best conduct clinical trials and development of vaccines in the context of an epidemic or outbreak.
At this panel discussion, two health policy experts examined the appropriate conduct of clinical trials during public health emergencies.
Learn more at: http://petrieflom.law.harvard.edu/events/details/clinical-trials-during-public-health-emergencies
This randomized controlled trial evaluated the effects of delayed cord clamping in preterm neonates. 78 mothers were randomly assigned to either early cord clamping (10 seconds), delayed cord clamping (60 seconds), or delayed cord clamping (60 seconds) plus intramuscular ergometrine administered to the mother. The primary outcome was hematocrit at 4 hours, with secondary outcomes including temperature on admission, hemodynamics, and morbidities. Delayed cord clamping, especially with ergometrine, was associated with higher hematocrit, temperature, blood pressure, and urinary output. This suggests delayed cord clamping provides better placental transfusion and transition for preterm neonates.
Enzalutamide showed significant benefits over placebo in preserving health-related quality of life in patients with metastatic castration-resistant prostate cancer based on EQ-5D data from the PREVAIL trial. Specifically, enzalutamide slowed the decline in EQ-5D index and visual analogue scale scores compared to placebo. Analysis of individual EQ-5D dimensions found that enzalutamide was associated with significantly less deterioration in pain/discomfort and anxiety/depression. Enzalutamide also showed benefits over placebo for time to worsening health status according to the EQ-5D.
Efficacy of a medical food in mild Alzheimer’s disease: A randomized, control...Nutricia
1. This randomized, double-blind, controlled trial investigated the effects of a medical food supplement called Souvenaid on cognitive function in 225 patients with mild Alzheimer's disease over 12 weeks.
2. The study found a statistically significant improvement in delayed verbal recall, the primary outcome measure, in the group receiving Souvenaid compared to the control group at 12 weeks.
3. Secondary measures of cognitive function, behavior, functional abilities, and quality of life did not differ between the groups. The medical food was well-tolerated with high compliance among patients.
Food for Thought: Souvenaid® in Mild Alzheimer’s DiseaseNutricia
1) A 24-week clinical trial tested the medical food Souvenaid, which contains nutrients thought to support synaptic function, in 259 patients with mild Alzheimer's disease.
2) The study achieved its primary outcome by showing a statistically significant difference in memory scores between the Souvenaid and placebo groups over 24 weeks.
3) Secondary analyses found some additional cognitive tests favored the Souvenaid group, while others showed no difference. EEG measures also showed some differences between groups. Souvenaid was well tolerated with few adverse effects.
New Perspectives on Alzheimer’s Disease and NutritionNutricia
This document summarizes a roundtable discussion on the role of nutrition in Alzheimer's disease (AD). The discussion focused on how being overweight or obese in midlife may increase the risk of developing AD decades later, though evidence is conflicting. After midlife, higher body weight and BMI are associated with lower dementia risk. Weight loss and underweight in late life are linked to higher dementia risk. The natural trajectory of BMI over the lifespan differs between those who do and do not develop dementia. Changes in BMI and weight loss may also be associated with clinical progression of AD. Further research is needed to better understand these complex relationships between nutritional status and AD risk and progression.
Gene therapy using an AAV vector was tested in 6 males with severe hemophilia B. The vector encoded Factor IX and was administered via peripheral vein infusion. No safety issues were found regarding germline transmission or formation of antibodies against FIX. Mild, transient elevations in liver enzymes occurred in some subjects. FIX levels increased in a dose-dependent manner, allowing 4 subjects to stop prophylactic FIX treatment without bleeding. While the study demonstrated proof-of-concept for hemophilia B gene therapy, larger trials are needed to further evaluate safety and efficacy.
This document summarizes a journal club presentation on a study assessing the knowledge and practices of intensive care nurses regarding the prevention of ventilator-associated pneumonia. The study found that the nurses had average knowledge but unsatisfactory practices in preventing VAP. It concluded that additional in-service education and training programs are needed to improve nurses' knowledge and practices and reduce infections among patients. The presentation reviewed the objectives, methods, findings and conclusions of the descriptive study conducted with 50 nurses in India. It also discussed relevant literature supporting the average knowledge levels found and the need for preventative protocols and guidelines.
Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...Nutricia
This document summarizes the conclusions of an expert panel convened by the International Association of Gerontology and Geriatrics to discuss early detection of cognitive impairment. The panel agreed that:
1) Validated screening tests that take 3 to 7 minutes can identify early cognitive impairment.
2) The most effective approach is to use both patient-reported and informant-reported screening tools.
3) Early cognitive impairment may have treatable components, and emerging evidence supports interventions like medical treatment, nutrition changes, and physical/cognitive exercise to delay or reduce decline.
Efficacy of Souvenaid in Mild Alzheimer’s Disease: Results from a Randomized,...Nutricia
1) This randomized controlled trial found that consumption of Souvenaid, a medical food containing nutrients to support synaptic function, led to improved memory performance over 24 weeks in patients with mild Alzheimer's disease compared to a control group.
2) The primary outcome measure, the memory domain z-score of the Neuropsychological Test Battery, was significantly higher in the Souvenaid group than the control group after 24 weeks.
3) Secondary EEG measures showed significantly different functional brain connectivity in the delta band between the groups over 24 weeks, supporting the hypothesis that Souvenaid affects synaptic activity.
A systematic review of 9 studies comparing PEG and NG tube feeding in adults with swallowing disturbances found:
1) PEG was associated with a lower risk of treatment failure, especially in patients with neurological diseases.
2) There was no significant difference in complication rates between PEG and NG tubes.
3) PEG may be associated with a decreased risk of pneumonia compared to NG tubes and longer survival time.
This document discusses the application of precision medicine to Alzheimer's disease. It begins with background on the history and concepts of precision medicine and Alzheimer's disease. Precision medicine aims to personalize treatment based on individual characteristics like genetics and biomarkers. For Alzheimer's, precision medicine could help identify at-risk groups, understand the disease process, and develop targeted treatments. The role of genetics in precision medicine for Alzheimer's is discussed. Future directions include incorporating precision medicine into clinical trials to further advance personalized prevention and treatment of Alzheimer's disease.
Consensus Guidelines on Management of Childhood Convulsive Status Epilepticusmandar haval
The document provides consensus guidelines for the evaluation and management of childhood convulsive status epilepticus in India. It was developed through a multi-disciplinary consensus workshop involving experts from across India. The guidelines define status epilepticus and discuss the epidemiology in India. They emphasize the importance of early pre-hospital management to initiate treatment as soon as possible. The initial management should consist of a parenteral benzodiazepine by any feasible route. Subsequent in-hospital management is also outlined. The aim is to provide a standardized, evidence-based protocol tailored for use in India given available resources and common etiologies.
The document discusses home care for patients with neuromuscular diseases, specifically focusing on whether general practitioners or specialized teams are better suited to provide care. It notes the benefits of both approaches but emphasizes the importance of support networks and multidisciplinary teams to ensure accessible, high quality, and personalized care for patients.
This document discusses the evidence that resident work hours should be reformed to improve resident and patient well-being. It summarizes research showing that sleep deprivation impairs clinical performance and increases medical errors. Studies found residents had high rates of depression, motor vehicle accidents, and obstetric complications due to long work hours and lack of sleep. The document advocates for collaborative efforts between medical schools, hospitals, and unions to implement work hour limits and enforce policies to promote resident and student health and safety.
This document discusses delirium in the ICU, including:
1) Delirium is a common syndrome in ICU patients characterized by inattention and cognitive dysfunction. It is associated with increased mortality, length of stay, and long-term cognitive impairment.
2) Implementing an ABCDE bundle including awakening trials, breathing coordination, delirium monitoring/management, and early mobility can reduce delirium incidence and improve outcomes.
3) Non-pharmacological interventions like reorientation, mobility, and minimizing sedative exposure are important for preventing and treating delirium.
The document summarizes a study that evaluated the effects of probiotic treatment on depression-related behaviors in rats fed either a control or high-fat diet. Key findings include:
1. Probiotic treatment significantly lowered depressive-like behavior in rats and improved performance in memory tests, regardless of diet.
2. Probiotics modulated cytokine production and expression of genes related to the hypothalamic-pituitary-adrenal axis and neuroplasticity.
3. Metabolomic analysis found probiotics significantly affected 13 plasma metabolites involved in immune function, glucose regulation, and neurotransmission.
Comparative evaluation of 2g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections. Indian Journal Of Pharmacology. August 2015;Vol. 47; Issue 4
Actrims 2016 opera poster hauser_p024 (1)BartsMSBlog
The document summarizes results from two Phase III clinical trials called OPERA I and OPERA II that compared the efficacy and safety of ocrelizumab (OCR) to interferon beta-1a (IFN β-1a) in patients with relapsing multiple sclerosis (RMS). Key results include:
1) OCR significantly reduced annualized relapse rates (ARR) by 46-47% compared to IFN β-1a in both studies. OCR also reduced disability progression and brain lesion activity to a greater extent than IFN β-1a.
2) A higher proportion of patients on OCR achieved no evidence of disease activity compared to those on IFN β-1a.
February 9, 2018
In the past several years, the United States has struggled to respond to viral outbreaks, such as Ebola and Zika. There is now an awareness of the need to rapidly develop vaccines and treatments for epidemics that can quickly spread from country to country. But questions remain as how to best conduct clinical trials and development of vaccines in the context of an epidemic or outbreak.
At this panel discussion, two health policy experts examined the appropriate conduct of clinical trials during public health emergencies.
Learn more at: http://petrieflom.law.harvard.edu/events/details/clinical-trials-during-public-health-emergencies
This randomized controlled trial evaluated the effects of delayed cord clamping in preterm neonates. 78 mothers were randomly assigned to either early cord clamping (10 seconds), delayed cord clamping (60 seconds), or delayed cord clamping (60 seconds) plus intramuscular ergometrine administered to the mother. The primary outcome was hematocrit at 4 hours, with secondary outcomes including temperature on admission, hemodynamics, and morbidities. Delayed cord clamping, especially with ergometrine, was associated with higher hematocrit, temperature, blood pressure, and urinary output. This suggests delayed cord clamping provides better placental transfusion and transition for preterm neonates.
Enzalutamide showed significant benefits over placebo in preserving health-related quality of life in patients with metastatic castration-resistant prostate cancer based on EQ-5D data from the PREVAIL trial. Specifically, enzalutamide slowed the decline in EQ-5D index and visual analogue scale scores compared to placebo. Analysis of individual EQ-5D dimensions found that enzalutamide was associated with significantly less deterioration in pain/discomfort and anxiety/depression. Enzalutamide also showed benefits over placebo for time to worsening health status according to the EQ-5D.
Efficacy of a medical food in mild Alzheimer’s disease: A randomized, control...Nutricia
1. This randomized, double-blind, controlled trial investigated the effects of a medical food supplement called Souvenaid on cognitive function in 225 patients with mild Alzheimer's disease over 12 weeks.
2. The study found a statistically significant improvement in delayed verbal recall, the primary outcome measure, in the group receiving Souvenaid compared to the control group at 12 weeks.
3. Secondary measures of cognitive function, behavior, functional abilities, and quality of life did not differ between the groups. The medical food was well-tolerated with high compliance among patients.
Food for Thought: Souvenaid® in Mild Alzheimer’s DiseaseNutricia
1) A 24-week clinical trial tested the medical food Souvenaid, which contains nutrients thought to support synaptic function, in 259 patients with mild Alzheimer's disease.
2) The study achieved its primary outcome by showing a statistically significant difference in memory scores between the Souvenaid and placebo groups over 24 weeks.
3) Secondary analyses found some additional cognitive tests favored the Souvenaid group, while others showed no difference. EEG measures also showed some differences between groups. Souvenaid was well tolerated with few adverse effects.
New Perspectives on Alzheimer’s Disease and NutritionNutricia
This document summarizes a roundtable discussion on the role of nutrition in Alzheimer's disease (AD). The discussion focused on how being overweight or obese in midlife may increase the risk of developing AD decades later, though evidence is conflicting. After midlife, higher body weight and BMI are associated with lower dementia risk. Weight loss and underweight in late life are linked to higher dementia risk. The natural trajectory of BMI over the lifespan differs between those who do and do not develop dementia. Changes in BMI and weight loss may also be associated with clinical progression of AD. Further research is needed to better understand these complex relationships between nutritional status and AD risk and progression.
Gene therapy using an AAV vector was tested in 6 males with severe hemophilia B. The vector encoded Factor IX and was administered via peripheral vein infusion. No safety issues were found regarding germline transmission or formation of antibodies against FIX. Mild, transient elevations in liver enzymes occurred in some subjects. FIX levels increased in a dose-dependent manner, allowing 4 subjects to stop prophylactic FIX treatment without bleeding. While the study demonstrated proof-of-concept for hemophilia B gene therapy, larger trials are needed to further evaluate safety and efficacy.
This document summarizes a journal club presentation on a study assessing the knowledge and practices of intensive care nurses regarding the prevention of ventilator-associated pneumonia. The study found that the nurses had average knowledge but unsatisfactory practices in preventing VAP. It concluded that additional in-service education and training programs are needed to improve nurses' knowledge and practices and reduce infections among patients. The presentation reviewed the objectives, methods, findings and conclusions of the descriptive study conducted with 50 nurses in India. It also discussed relevant literature supporting the average knowledge levels found and the need for preventative protocols and guidelines.
Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...Nutricia
This document summarizes the conclusions of an expert panel convened by the International Association of Gerontology and Geriatrics to discuss early detection of cognitive impairment. The panel agreed that:
1) Validated screening tests that take 3 to 7 minutes can identify early cognitive impairment.
2) The most effective approach is to use both patient-reported and informant-reported screening tools.
3) Early cognitive impairment may have treatable components, and emerging evidence supports interventions like medical treatment, nutrition changes, and physical/cognitive exercise to delay or reduce decline.
Efficacy of Souvenaid in Mild Alzheimer’s Disease: Results from a Randomized,...Nutricia
1) This randomized controlled trial found that consumption of Souvenaid, a medical food containing nutrients to support synaptic function, led to improved memory performance over 24 weeks in patients with mild Alzheimer's disease compared to a control group.
2) The primary outcome measure, the memory domain z-score of the Neuropsychological Test Battery, was significantly higher in the Souvenaid group than the control group after 24 weeks.
3) Secondary EEG measures showed significantly different functional brain connectivity in the delta band between the groups over 24 weeks, supporting the hypothesis that Souvenaid affects synaptic activity.
A systematic review of 9 studies comparing PEG and NG tube feeding in adults with swallowing disturbances found:
1) PEG was associated with a lower risk of treatment failure, especially in patients with neurological diseases.
2) There was no significant difference in complication rates between PEG and NG tubes.
3) PEG may be associated with a decreased risk of pneumonia compared to NG tubes and longer survival time.
This document discusses the application of precision medicine to Alzheimer's disease. It begins with background on the history and concepts of precision medicine and Alzheimer's disease. Precision medicine aims to personalize treatment based on individual characteristics like genetics and biomarkers. For Alzheimer's, precision medicine could help identify at-risk groups, understand the disease process, and develop targeted treatments. The role of genetics in precision medicine for Alzheimer's is discussed. Future directions include incorporating precision medicine into clinical trials to further advance personalized prevention and treatment of Alzheimer's disease.
Consensus Guidelines on Management of Childhood Convulsive Status Epilepticusmandar haval
The document provides consensus guidelines for the evaluation and management of childhood convulsive status epilepticus in India. It was developed through a multi-disciplinary consensus workshop involving experts from across India. The guidelines define status epilepticus and discuss the epidemiology in India. They emphasize the importance of early pre-hospital management to initiate treatment as soon as possible. The initial management should consist of a parenteral benzodiazepine by any feasible route. Subsequent in-hospital management is also outlined. The aim is to provide a standardized, evidence-based protocol tailored for use in India given available resources and common etiologies.
The document discusses home care for patients with neuromuscular diseases, specifically focusing on whether general practitioners or specialized teams are better suited to provide care. It notes the benefits of both approaches but emphasizes the importance of support networks and multidisciplinary teams to ensure accessible, high quality, and personalized care for patients.
This document discusses the evidence that resident work hours should be reformed to improve resident and patient well-being. It summarizes research showing that sleep deprivation impairs clinical performance and increases medical errors. Studies found residents had high rates of depression, motor vehicle accidents, and obstetric complications due to long work hours and lack of sleep. The document advocates for collaborative efforts between medical schools, hospitals, and unions to implement work hour limits and enforce policies to promote resident and student health and safety.
This document discusses delirium in the ICU, including:
1) Delirium is a common syndrome in ICU patients characterized by inattention and cognitive dysfunction. It is associated with increased mortality, length of stay, and long-term cognitive impairment.
2) Implementing an ABCDE bundle including awakening trials, breathing coordination, delirium monitoring/management, and early mobility can reduce delirium incidence and improve outcomes.
3) Non-pharmacological interventions like reorientation, mobility, and minimizing sedative exposure are important for preventing and treating delirium.
Delirium in critically ill patients bogota043009hospira2010
The document discusses acute brain dysfunction, specifically delirium, in critically ill patients. Some key points:
- Delirium affects 60-80% of ICU patients and is underdiagnosed. It is linked to higher costs, longer hospital stays, and increased risk of death.
- Survivors often experience long-term cognitive impairment equivalent to mild/moderate dementia.
- Sedatives like benzodiazepines and opioids are risk factors for delirium. Protocols aiming to reduce exposure can help prevent delirium.
- Studies found the alpha-2 agonist dexmedetomidine reduced delirium and cognitive dysfunction compared to lorazepam. Antipsychotics may help
Critical care involves managing organ system failures while considering the overall clinical picture of the patient. Less invasive interventions are preferred when possible to avoid iatrogenic harm. Prognostication is difficult, and outcomes depend on the individual patient's values and preferences. Family meetings require skilled communication to make difficult end-of-life decisions. The goal is providing humane care that aligns with patient priorities through a team-based approach.
This document discusses how telehealth and real-time analytics can help critical care achieve better health outcomes, better care, and lower costs. It describes how monitoring patients and gaining situation awareness is important for critical care. Real-time data analytics can help clinicians understand a patient's current physiological status and trajectory. Pattern recognition in patient data may help identify issues earlier. The challenges of big data in healthcare including volume, velocity, variety and veracity are discussed. Technologies that provide real-time situation awareness and predictive analytics could help improve patient care and outcomes in the ICU.
This document discusses how telehealth and real-time analytics can help critical care achieve better health outcomes, better care, and lower costs. It describes how monitoring patients and gaining situation awareness is important for critical care. Real-time data analytics can help clinicians understand a patient's current physiological status and trajectory. Pattern recognition in patient data may help identify issues earlier. The challenges of big data in healthcare including volume, velocity, variety and veracity are discussed. Technologies that provide real-time situation awareness and predictive analytics could help improve patient care and outcomes in the ICU.
Brief Report: OSA Evaluations for the Anaesthesiologist, Surgeon, Surgery Centresemualkaira
This short report presents a scope of the medical condition of Obstructive Sleep Apnea (OSA). Current methods for assessment and
diagnosis of OSA are presented. Complications and potential death
from untreated OSA places the anesthesiologist, surgeon and surgical center in a risk situation. Factors related to the risk factors
and points toward resolution are presented.
This document provides information about discussing goals of care with family members of patients with dementia. It begins with an introduction and outlines the session goals. It then discusses the natural history and progression of Alzheimer's disease using the FAST scale. Data on the clinical course of advanced dementia is presented showing high rates of infections, eating problems, and burdensome interventions in the last months of life. Evidence is discussed regarding treating or not treating pneumonia and tube feeding. The role play provides an example case of a patient with advanced dementia to discuss goals of care.
This document discusses delirium in the ICU. It begins with definitions of delirium and discusses its high prevalence among ICU patients, up to 70%. The pathophysiology is not fully understood but may involve disturbances in neurotransmitters like acetylcholine. Precipitants include medications, infections, metabolic disturbances and physical immobilization. Diagnosis involves tools like the Confusion Assessment Method. Management prioritizes prevention, treating underlying causes, and supportive care with low-dose short-acting medications as needed to manage severe symptoms.
This document discusses varicella zoster virus (VZV) which causes chickenpox and shingles. It provides statistics on the incidence of chickenpox pre- and post-vaccine era in the US. It also discusses risk factors for shingles and strategies to reduce its incidence including exposure to children with chickenpox and the shingles vaccine.
This document summarizes psychiatric disorders that are more prevalent in HIV-infected patients compared to the general population. It discusses how psychiatric illness can both increase the risk of HIV infection and negatively impact outcomes for HIV patients. Common psychiatric issues in HIV patients include depression, anxiety, substance abuse, and mania. Screening tools and treatment options are also reviewed.
This study evaluated shock index (SI), defined as heart rate divided by systolic blood pressure, as a predictor of morbidity and mortality in pediatric trauma patients. The study used data from the 2010 National Trauma Data Bank and found that an elevated age-adjusted SI was strongly associated with mortality, need for blood transfusion, ventilation, procedures, and ICU stay. Compared to hypotension alone, elevated SI had improved sensitivity for predicting negative outcomes while maintaining high specificity. The findings support using SI as a simple tool to identify pediatric trauma patients at risk of shock-related complications.
Long-term cognitive impairment after critical illness (CIACI) is frequently reported in up to 66% of patients three months after intensive care hospitalization. The condition has overlapping neurological changes with stroke, traumatic brain injury, and neurodegenerative disorders. Risk factors for CIACI include depression, biomarkers for Alzheimer's disease, delirium duration during hospitalization, and exposure to certain drugs. Current strategies to prevent or treat CIACI focus on reducing delirium and agitation, as well as physical and cognitive rehabilitation. Neurotrophic factors may play a role in neurogenesis, blood-brain barrier integrity, and neuronal repair, suggesting they could be a potential target for novel CIACI treatments.
The document discusses amyotrophic lateral sclerosis (ALS) and focuses on respiratory assessment and ventilatory management of patients with ALS. It highlights the importance of a multidisciplinary team approach and early systematic respiratory evaluation to improve outcomes. Prognosis is difficult to predict for individual patients but median survival time is around 3-5 years from time of diagnosis.
Interventional spine & pain management dr manish rajManish Raj
This document provides an overview of chronic pain and interventional pain management techniques. It defines chronic pain as pain that lasts more than 3 months and outlines its prevalence and impact, noting it affects more Americans than diabetes, heart disease, and cancer combined. Interventional pain management aims to decrease or eliminate pain through minimally invasive techniques like injections, radiofrequency ablation, and spinal cord or peripheral nerve stimulation. The document reviews common causes of back pain and neck pain, as well as conditions treated by interventional techniques. It also discusses evidence-based guidelines for interventional pain management and the multidisciplinary approach needed for successful chronic pain treatment.
Vns Therapy™ System For Weikong For Printcalaf0618
The document discusses VNS Therapy, a treatment for epilepsy patients who have difficulty controlling seizures through medications alone. It provides information on:
- How VNS Therapy works by electrically stimulating the vagus nerve to impact brain regions involved in seizure activity.
- Clinical evidence that VNS Therapy can significantly reduce seizure frequency in refractory epilepsy patients and improve quality of life factors like mood and alertness.
- Safety data showing the risks of VNS Therapy are low, with most side effects being mild and transient.
- High patient and clinician satisfaction rates with VNS Therapy as an effective alternative or addition to medications for difficult-to-treat epilepsy.
This document summarizes research on prion diseases like Creutzfeldt-Jakob disease (CJD). It discusses the causes of prion diseases including genetic mutations and spontaneous misfolding. The document outlines the clinical diagnosis and tests used to diagnose CJD. It also describes recent investigational treatments for CJD like quinacrine, pentosan polysulfate, and doxycycline. Finally, it provides an overview of resources for patients and their families dealing with prion diseases.
Georgetown University Hospital Dept of Medicine Grand Roundsapplebyb
This document discusses Creutzfeldt-Jakob disease (CJD), a rare neurological prion disease. It covers the objectives of understanding diagnosis of CJD and managing patients with CJD. It describes the different etiologies of CJD including genetic, variant, and acquired forms. Diagnosis involves clinical signs, EEG, CSF tests, and MRI imaging. Experimental treatments including quinacrine, pentosan polysulphate, and doxycycline are summarized. Care and management of CJD involves education, communication, and symptom management, with the goals of caring for patients and supporting families during the disease course.
Delirium in ICU: Nomenclature and DiagnosisSimone Piva
The document discusses delirium screening tools used in the intensive care unit (ICU). It notes that the Confusion Assessment Method for the ICU (CAM-ICU) involves a one-minute assessment while the Intensive Care Delirium Screening Checklist (ICDSC) evaluates patients over 8-24 hours. The longer assessment period of the ICDSC may increase the detection of delirium fluctuations but also potentially false positives if symptoms were present in the past 24 hours but not currently. The CAM-ICU uses specifically defined measures requiring patient interaction while the ICDSC relies on observation, with each tool having potential advantages and disadvantages depending on patient factors.
This is a presentation done on 4/6/11 for the Grand Rounds at Wayne State university by Pallav Pareek M.D.
This presentation talks about the concept of prdrome as it is(if?) applicable to schizophrenia, and if schizophrenia is becoming more of a preventable illness as science progresses. If so what are the various ways and means in which we can accomplish this prevention.
Amidst so much controversy on the issue , whether there is a prodrome for this illness or not, here I have tried to present the recent advances in this field and the recent scientific literature in this regard.
Similar to Journal club: long-term cognitive impairment after critical illness [NEJM 369] (20)
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Journal club: long-term cognitive impairment after critical illness [NEJM 369]
1. JOURNAL CLUB
LONG-TERM COGNITIVE IMPAIRMENT
AFTER CRITICAL ILLNESS
JOÃO MELO ALVES, MD
LISBOA, PORTUGAL
--
INTERNAL MEDICINE ICU
DIRECTOR: PROF. VAN-HEERDEN VERNON, MD
HADASSAH EIN KEREM UNIVERSITARY HOSPITAL
JERUSALEM
2. PROLOGUE
JOURNAL CLUB
EPILOGUE
THE STUDY
BRAIN-ICU
Bringing to Light the Risk Factors and Incidence of Neuropsychological
Dysfunction in ICU survivors
Pratik Pandharipande, MD
American Board of Anesthesiology – Anesthesiology & Critical Care
American College of Critical Care Medicine – Fellow
Professor of Anesthesiology, Vanderbilt University School of Medicine
Multicenter prospective cohort
Nashville (Tennessee, USA)
Vanderbilt University Medical Center Saint Thomas Hospital
5. DELIRIUM
Disturbance of consciousness with inattention
Acute change in cognition
(memory, disorientation, language, perception)
Acute onset (hours to days) & fluctuating course
Clinical evidence that it is secondary to a medical condition
TIME COURSE
Prevalent
Incident
Persistent
MOTORIC SUBTYPES
Hyperactive
Hypoactive
Mixed
Subsyndromal
Sumperimposed on
dementia
DSM-IV-TR
Diagnostic and Statistical Manual 4th ed. American
Psychiatric Association. APA Press, 2013.
DEFINITIONS
PROLOGUE
JOURNAL CLUB
EPILOGUE
6. LTCI-CI
Long-term cognitive impairment after critical illness
RBANS
Repeatable Battery for the Assessment of Neuropsychological Status
TWO TESTS < 2 S.D.
THREE TESTS < 1.5 S.D.
MCI
AD
(…)
A. Morandi, PP Pandharipande et. al
Best Pract Res Clin Anaesthesiol 26 (2012) 267-276
DEFINITIONS
PROLOGUE
JOURNAL CLUB
EPILOGUE
7. LTCI-CI
Long-term cognitive impairment after critical illness
RBANS
Repeatable Battery for the Assessment of Neuropsychological Status
TWO TESTS < 2 S.D.
THREE TESTS < 1.5 S.D.
MCI
AD
(…)
A. Morandi, PP Pandharipande et. al
Best Pract Res Clin Anaesthesiol 26 (2012) 267-276
DEFINITIONS
PROLOGUE
JOURNAL CLUB
EPILOGUE
Reitan RM. Percept Mot Skills 1958 (8)
8. LTCI-CI
Long-term cognitive impairment after critical illness
RBANS
Repeatable Battery for the Assessment of Neuropsychological Status
TWO TESTS < 2 S.D.
THREE TESTS < 1.5 S.D.
MCI
AD
(…)
A. Morandi, PP Pandharipande et. al
Best Pract Res Clin Anaesthesiol 26 (2012) 267-276
DEFINITIONS
PROLOGUE
JOURNAL CLUB
EPILOGUE
10. LTCI-CI
Small cohorts
Individual disease processes
Large studies lacking in-hospital
RF assessment
LIMITED
EVIDENCE
Multicenter prospective cohort study of a diverse critically ill population
Prevalence of LTCI-CI
Hypothesis: duration of delirium, doses of sedation/analgesia
?
BACKGROUND
PROLOGUE
JOURNAL CLUB
EPILOGUE
11. ADULTS
medical or surgical ICU
respiratory failure
cardiogenic shock
septic shock
(…)
DELIRIUM
Number of hospital days
SEDATION / ANALGESIA
3 MONTHS
12 MONTHS
IN-HOSPITAL
POST-DISCHARGE
METHODS
PROLOGUE
JOURNAL CLUB
EPILOGUE
12. ADULTS
medical or surgical ICU
respiratory failure
cardiogenic shock
septic shock
(…)
DELIRIUM
Number of hospital days
SEDATION / ANALGESIA
3 MONTHS
12 MONTHS
IN-HOSPITAL
POST-DISCHARGE
METHODS
PROLOGUE
JOURNAL CLUB
EPILOGUE
Covariates
Age
Years of education
Chronic disease burden (Charlson comorbidity index)
Preexisting cognitive impairment (short IQCODE)
Cerebrovascular disease (Framingham Stroke Risk Profile)
Apolipoprotein E genotype
Daily SOFA
Mean daily dose Haloperidol
Duration of severe sepsis, hypoxemia, coma
Multiple linear regression
adjustament for covariates
separate models for 3 and 12 months
13. PROLOGUE
JOURNAL CLUB
EPILOGUE
RESULTS
March 2007 – May 2010
821 patients
HOSPITAL
MONTH 3
MONTH 12
74% had delirium
569 survivors
510 survirors
COGNITIVE TESTING
448
382
467 patients underwent follow-up
at 3 and/or 12 months
19. 3 MONTHS
12 MONTHS
IN-HOSPITAL
POST-DISCHARGE
RESULTS – RISK FACTORS
PROLOGUE
JOURNAL CLUB
EPILOGUE
p=0.001 p=0.004
p=0.04 p=0.007
Global RBANS Executive function
DELIRIUM
SEDATION / ANALGESIA
individual
RBANS
domains
20.
21. Causal role?
Mechanisms?
Inflammation and neuronal apoptosis brain atrophy and loss of white matter
integrity
Van Gool WA et al. Lancet 2010 (375)
Cunningham C. Biochem Soc Trans 2011 (39)
Gunther ML et al. Crit Care Med 2012 (40)
Morandi A et al. Crit Care Med 2012 (40)
PROLOGUE
JOURNAL CLUB
EPILOGUE
DISCUSSION
≤Alzheimer’s ≤ TBI
These profound cognitive deficits
were new in the majority of patients,
and affected both old and young
patients, regardless of the burden of
coexisting illnesses at baseline
Longer duration of delirium worse long-term global cognition and executive function
Independent of sedation, analgesia, age, preexistent cognitive impairment, coexisting conditions and SOFA score
22. Groundbreaking study
A role for interventions targeted at reducing delirium duration?
Limitations
Previous cognitive function not assessed
Patients with incomplete data
Unmeasured confounders?
PROLOGUE
JOURNAL CLUB
EPILOGUE
DISCUSSION
23. Reliability of delirium assessment
Letter to the editor (NEJM 370;2 p184)
PROLOGUE
JOURNAL CLUB
EPILOGUE
BEYOND THE JOURNAL CLUB
“sedation confounds delirium assessement, especially with the CAM-ICU”
“patients who are awake in the ICU have a much lower prevalence of
delirium than more sedated patients”
“as sedation decreases and RASS increases, rate of delirium assessed by
CAM-ICU drops precipitously”
24. “unequivocally establishes”
“ a new standard of longitudinal cognitive-outcome studies”
“herculean efforts to track patients and conduct blinded cognitive assessments”
“prior observations suggesting drug exposures are clear risk factors were not supported”
PROLOGUE
JOURNAL CLUB
EPILOGUE
BEYOND THE JOURNAL CLUB
Herridge M, Cameron JI. NEJM 369;14
25. “unequivocally establishes”
“ a new standard of longitudinal cognitive-outcome studies”
“herculean efforts to track patients and conduct blinded cognitive assessments”
“prior observations suggesting drug exposures are clear risk factors were not supported”
PROLOGUE
JOURNAL CLUB
EPILOGUE
BEYOND THE JOURNAL CLUB
Herridge M, Cameron JI. NEJM 369;14
“it would be important to gain an appreciation of how the brain-activity
interface affects functional independence, quality of life and patient-
centered outcomes (…) job loss, healthcare utilization, family
caregivers”
“risk stratification will help distinguish patients who can regain
functional independence and those who have exhausted their organ
reserve and rehabilitive potential and who live in the purgatory of
critical illness only to have unacceptably poor outcomes”
“should fuel an informed discussion about what it means for our patients
to survive and episode of critical illness (…) when the degree of suffering
and futility becomes unacceptable from a patient-centered and societal
standpoint”
26. Duration of ICU delirium vs. disability and physical health status
N=126
CAM-ICU vs. Katz activities of daily living (…)
PROLOGUE
JOURNAL CLUB
EPILOGUE
BEYOND THE JOURNAL CLUB
Crit Care Med 2014 (42)
worse activities of daily living scores at 12m (p=0.002)
worse motor-sensory function (p=0.02)
27. PROLOGUE
JOURNAL CLUB
EPILOGUE
BEYOND THE JOURNAL CLUB
Lancet Resp Med 2014 (2)
3 months 12 months
depression 37% 33%
PTSD 7% 7%
basic activities of daily living 32% 27%
instrumental activities of daily living 26% 23%
(no consistent association between delirium and outcomes…)
28. BEYOND THE JOURNAL CLUB
PREVENT
Orientation protocols
Cognitive stimulation
Physiologic sleep
(e.g. lighting, earplugs)
Early mobilization, avoid restraints
Visual/hearing aids
Monitor orders (e.g. bzd)
Pain
BUNDLES!
TREAT
THE
CAUSE
MANAGE SYMPTOMS
Hyperactive only!
Nonpharmacological
interventions
LOW DOSE, SHORT ACTING, PRN
drugs
Neuroleptics
Atypical antipsichotics
BZD
CholE inhib?
PROLOGUE
JOURNAL CLUB
EPILOGUE
32. 1. Pandharipande PP et al. Long-term cognitive impairment after critical illness. N Engl J Med 369 (2013);14,
1306-1316
2. Morandi A, Pandharipande PP et al. Understanding terminology of delirium and long-term cognitive
impairment in critically ill patients. Best Pract Res Clin Anaesthesiol 26 (2012) 267-276
3. Herridge M, Cameron JI. Disability after critical illness (editorial). N Engl J Med 2013 (369:14)
4. Fraser GL, Riker RR, Coursin DC. (letter to the editor).N Engl J Med 2014 (370:2)
5. Brummel NE et al. Delirium in the ICU and subsequent long-term disability among survivors of
mechanical ventilation. Crit Care Med 2014 (42:2)
6. Jackson JC et al. Depression, post-traumatic stress disorder and functional disability in survivors of
critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med 2014 (2)